Back to search

Article

Integrative Pharmacogenomics Analysis of Patient Derived Xenografts

2018-11-16

Abstract excerpt

<h4>ABSTRACT</h4> One of the key challenges in cancer precision medicine is finding robust biomarkers of drug response. Patient-derived tumor xenografts (PDXs) have emerged as reliable preclinical models since they better recapitulate tumor response to chemo- and targeted therapies. However, the lack of standard tools poses a challenge in the analysis of PDXs with molecular and pharmacological profiles. Efficient...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c009516e-e7fb-5315-8a8e-41aedfa17458
DOI
10.1101/471227
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrative Pharmacogenomics Analysis of Patient Derived XenograftsDOI 10.1101/471227
Select a neighboring publication to make it the new centre.